RecombiMAb human IgG4 (S228P) isotype control, anti-respiratory syncytial virus

Catalog #CP152
Clone:
Palivizumab-CP152
Reactivities:
Virus

$217.00 - $5,910.00

Choose an Option...
  • 100 mg - $5,910.00
  • 50 mg - $4,229.00
  • 25 mg - $2,942.00
  • 5 mg - $843.00
  • 1 mg - $217.00
  • Custom Amount (Quotes Only)
In stock
Only %1 left

Product Details

This human IgG4 S228P isotype control antibody reacts with respiratory syncytial virus and has low or no specific binding to any human sample.  The S228P mutation is included to prevent IgG4 Fab exchange. This is a recombinant human IgG4 antibody produced in CHO cells.

Specifications

Isotype Human IgG4, κ
Recommended Dilution Buffer InVivoPure pH 7.0 Dilution Buffer
Mutations S228P
Formulation PBS, pH 7.0
Contains no stabilizers or preservatives
Endotoxin <1EU/mg (<0.001EU/μg)
Determined by LAL gel clotting assay
Purity >95%
Determined by SDS-PAGE
Sterility 0.2 µm filtration
Production Purified from CHO cell supernatant
Purification Protein G
Molecular Weight 150 kDa
Storage The antibody solution should be stored at the stock concentration at 4°C. Do not freeze.